Drinking from the fountain of promise: biomarkers in the surveillance of Barrett's oesophagus--the glass is half full!
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 16966694.
- Also identified by PMC identifier 1856442.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Biomarkers for prognostication need large randomised controlled trials such as AspECT and BOSS. These trials will deliver surrogates which fulfil the validation criteria necessary for their introduction into the clinic
Medical subject headings
- Barrett Esophagus
- Biomarkers, Tumor
- Esophageal Neoplasms